Leptin-driven fatty acid β-oxidation (FAO) activation enhances the proinflammatory characteristics of FLS in RA, and the proinflammatory phenotype of RA-FLS can be inhibited by silencing leptin expression or with etomoxir, a well-known FAO pathway inhibitor 23. Here, LEP is linked to rheumatoid arthritis.